Zdrowie i gospodarka · 06/05/2026
FDA Classifies Circulating Tumor Cell Enrichment Device as Class II
The FDA has classified the circulating tumor cell enrichment device as Class II, a move expected to enhance patients' access to innovative devices while ensuring safety and effectiveness.